array:23 [ "pii" => "S0025775301717733" "issn" => "00257753" "doi" => "10.1016/S0025-7753(01)71773-3" "estado" => "S300" "fechaPublicacion" => "2001-01-01" "aid" => "71773" "copyright" => "Elsevier España, S.L.. Todos los derechos reservados" "copyrightAnyo" => "2001" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Med Clin. 2001;116:209-13" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1390 "formatos" => array:3 [ "EPUB" => 7 "HTML" => 1204 "PDF" => 179 ] ] "itemSiguiente" => array:18 [ "pii" => "S0025775301717745" "issn" => "00257753" "doi" => "10.1016/S0025-7753(01)71774-5" "estado" => "S300" "fechaPublicacion" => "2001-01-01" "aid" => "71774" "copyright" => "Elsevier España, S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Med Clin. 2001;116:214-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2600 "formatos" => array:3 [ "EPUB" => 7 "HTML" => 2081 "PDF" => 512 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Conversión a esclerosis múltiple clínicamente definida tras un síndrome medular aislado: valor de la resonancia magnética craneal y medular" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "214" "paginaFinal" => "216" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Conversion to clinically definite multiple sclerosis after isolated spinal cord syndrome: value of brain and spinal MRI" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:2 [ 0 => array:2 [ "autoresLista" => "Imma Pericot, Mar Tintoré, Luis Brieva, Xavier Montalbán" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Imma" "apellidos" => "Pericot" ] 1 => array:2 [ "nombre" => "Mar" "apellidos" => "Tintoré" ] 2 => array:2 [ "nombre" => "Luis" "apellidos" => "Brieva" ] 3 => array:2 [ "nombre" => "Xavier" "apellidos" => "Montalbán" ] ] ] 1 => array:2 [ "autoresLista" => "Elisenda Grivé, Alex Rovira" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Elisenda" "apellidos" => "Grivé" ] 1 => array:2 [ "nombre" => "Alex" "apellidos" => "Rovira" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775301717745?idApp=UINPBA00004N" "url" => "/00257753/0000011600000006/v1_201307291450/S0025775301717745/v1_201307291450/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0025775301717721" "issn" => "00257753" "doi" => "10.1016/S0025-7753(01)71772-1" "estado" => "S300" "fechaPublicacion" => "2001-01-01" "aid" => "71772" "copyright" => "Elsevier España, S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Med Clin. 2001;116:206-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1802 "formatos" => array:3 [ "EPUB" => 4 "HTML" => 1427 "PDF" => 371 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Influencia de la menopausia en la concentración plasmática de homocisteína" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "206" "paginaFinal" => "208" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Influence of menopausal status in homocysteine plasma levels" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Consuelo Fernández-Miranda, María de la Calle, José Manuel Bris, Mercedes Muelas, Pilar Gómez, Pilar Díaz-Rubio" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Consuelo" "apellidos" => "Fernández-Miranda" ] 1 => array:2 [ "nombre" => "María" "apellidos" => "de la Calle" ] 2 => array:2 [ "nombre" => "José" "apellidos" => "Manuel Bris" ] 3 => array:2 [ "nombre" => "Mercedes" "apellidos" => "Muelas" ] 4 => array:2 [ "nombre" => "Pilar" "apellidos" => "Gómez" ] 5 => array:2 [ "nombre" => "Pilar" "apellidos" => "Díaz-Rubio" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775301717721?idApp=UINPBA00004N" "url" => "/00257753/0000011600000006/v1_201307291450/S0025775301717721/v1_201307291450/es/main.assets" ] "es" => array:14 [ "idiomaDefecto" => true "titulo" => "Análisis poblacional de la necesidad de cambios y tasas de continuidad de los diferentes fármacos antihipertensivos" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "209" "paginaFinal" => "213" ] ] "autores" => array:2 [ 0 => array:4 [ "autoresLista" => "Francisco Javier Sierra Alonso, Carlos Lagarejos Tricas, Francisco Cirujano Pita, Natalia Villalba Guijorro, M.<span class="elsevierStyleSup">a</span> Jesús Muñoz Sanz" "autores" => array:5 [ 0 => array:3 [ "nombre" => "Francisco" "apellidos" => "Javier Sierra Alonso" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Carlos" "apellidos" => "Lagarejos Tricas" ] 2 => array:2 [ "nombre" => "Francisco" "apellidos" => "Cirujano Pita" ] 3 => array:2 [ "nombre" => "Natalia" "apellidos" => "Villalba Guijorro" ] 4 => array:2 [ "nombre" => "M.<span class="elsevierStyleSup">a</span>" "apellidos" => "Jesús Muñoz Sanz" ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Centro de Salud Prosperidad. Hospital La Princesa. Área II. Madrid." ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "*" "correspondencia" => "Correspondencia: Dr. F.J. Sierra Alonso. Centro de Salud Castelló. Castelló, 63. 28001 Madrid." ] ] ] 1 => array:3 [ "autoresLista" => "Francisco Rodríguez Salvanés" "autores" => array:1 [ 0 => array:3 [ "nombre" => "Francisco" "apellidos" => "Rodríguez Salvanés" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:3 [ "entidad" => "Unidad de Epidemiología Clínica. Hospital La Princesa. Área II. Madrid." "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "A population-based study of need for changes and continuing rates of antihypertensive drugs" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2000-08-23" "fechaAceptado" => "2001-01-09" "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec221349" "palabras" => array:3 [ 0 => "Fármacos antihipertensivos" 1 => "Cambio de tratamiento" 2 => "Práctica clínica" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec221348" "palabras" => array:3 [ 0 => "Antihipertensive agents" 1 => "Clinical practice" 2 => "Discontinuing of therapy" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:1 [ "resumen" => "<span class="elsevierStyleSectionTitle">Fundamento</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">El tratamiento farmacológico de la hipertensión arterial precisa ser modificado frecuentemente por ineficacia o intolerancia. El objetivo del presente trabajo es comparar la incidencia de cambios de los nuevos fármacos antihipertensivos frente a los clásicos bloqueadores beta y diuréticos, además de definir en el tiempo la probabilidad de continuidad de cada grupo.</p> <span class="elsevierStyleSectionTitle">Material y método</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Se revisaron las historias clínicas de los hipertensos de un centro de salud y se registraron los cambios y sus causas en el período de octubre de 1997 a septiembre de 1999. Se calculó la incidencia de cambio por efecto adverso, ineficacia y global de cada grupo, así como los riesgos relativos de cambio de todos frente a bloqueadores beta, diuréticos, inhibidores de la enzima conversiva de la angiotensina (IECA) y antagonistas de los receptores de la angiotensina-II (ARA-II). Mediante tablas de vida se describe la probabilidad acumulada de continuidad.</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">El 27,6% de los 786 tratamientos evaluados tuvieron que ser cambiados, el 51,4% de ellos por efectos adversos y el 29,8% por ineficacia. La probabilidad de continuidad era del 88% a los 3 meses, del 81% a los 6 meses, del 71% al año y del 54% a los 2 años. Los cambios por intolerancia ocurrieron en el 51% en los primeros 3 meses, y el riesgo persistió después en el tiempo. La incidencia de cambios globales por 1.000 meses de prescripción fue la siguiente: ARA-II, 17,1; bloqueadores beta, 18,4; combinación IECA-diurético, 22,7; IECA, 23,7; diuréticos, 35,4; antagonistas del calcio, 37,4, y bloqueadores alfa, 42,2. El análisis de cambios por efectos adversos dio resultados muy similares. Los antagonistas del calcio tuvieron, respecto al resto, un riesgo significativamente superior de cambio por este motivo. Las tasas de continuidad fueron superiores para bloqueadores beta y ARA-II, seguidos de IECA y la combinación IECA-diurético</p> <span class="elsevierStyleSectionTitle">Conclusión</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Los fármacos antihipertensivos se cambian con más frecuencia de lo deseable y tienen unas bajas tasas de continuidad. Las diferencias observadas en la incidencia de cambios y tasas de continuidad entre los diferentes grupos farmacológicos no justifican, en sí mismas, la necesidad de modificar la recomendación general de utilizar los bloqueadores beta y diuréticos como primera elección en el tratamiento inicial de la hipertensión arterial.</p>" ] "en" => array:1 [ "resumen" => "<span class="elsevierStyleSectionTitle">Background</span><p id="spar00025" class="elsevierStyleSimplePara elsevierViewall">Antihypertensive drugs are frequently changed because of inefficacy and adverse effects. The aim of this study was to compare the incidence of changes of the new classes of drugs from the classical ß-blockers and diuretics. We also have calculated the probability of continuing with each class of drug.</p> <span class="elsevierStyleSectionTitle">Material and method</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Clinical reports of hypertensive patients of a general practice centre were examined. All changes of treatment and their causes were registered between october 1997 and september 1999. The incidences for global changes and also for intolerance and ineficacy changes were calculated for each drug. Relative risks for ß-blockers, diuretics, ACE inhibitors of anhidride carbonic enzyme and angiotensine II-receptor-antagonists were analized. The cumulated probability for continuing therapy was also studied.</p> <span class="elsevierStyleSectionTitle">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">27.6% out of 786 courses of treatment were changed, 51.4% due to intolerance and 29,8% due to inefficacy. The probability for continuing was 88% after 3 months, 81% after 6 months, 71% after one year and 54% after 2 years. The probability for discontinuing because of intolerance was higher in the first 3 months (51%), but afterwards it remained stable along the time.</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Anthypertensive drugs are discontinued more frequently than what it would be desirable and their continuing rates are low. Differences observed among each class of drugs are not argument enough for changing the general recommendation of using ß-blockers and diuretics as first choice drugs for initial treatment of hypertension.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Referencias Bibliográficas" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:26 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalencia e importancia sanitaria de la hipertensión arterial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R. Tresserras" 1 => "H. Pardell" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "An Med Intern (Madr)" "fecha" => "1990" "volumen" => "7" "numero" => "Supl 3" "paginaInicial" => "1" "paginaFinal" => "6" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "El coste de la hipertensión arterial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "X. Badía" 1 => "J. Rovira" 2 => "R. Tresserras" 3 => "C. Trinxet" 4 => "J. Segú" 5 => "H. Pardell" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "paginaInicial" => "39" "paginaFinal" => "62" "serieFecha" => "1998" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "titulo" => "World Health Organization. Targets for health for all" ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:1 [ "serieFecha" => "1985" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiología de la hipertensión arterial en España. Prevalencia, conocimiento y control" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.R. Banegas" 1 => "F. Rodríguez-Artalejo" 2 => "A. Graciani" 3 => "F. Villar" 4 => "Guallar-Castillón" 5 => "J.J. De la Cruz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Hipertensión" "fecha" => "1999" "volumen" => "16" "paginaInicial" => "315" "paginaFinal" => "322" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Blood pressure in Spain: distribution, awareness, control and benefits of a reduction in average pressure" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.R. Banegas" 1 => "F. Rodríguez-Artalejo" 2 => "J.J. Cruz" 3 => "P. Guallar" 4 => "J. Rey" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Hypertension" "fecha" => "1998" "volumen" => "32" "paginaInicial" => "998" "paginaFinal" => "1002" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9856963" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "¿El tratamiento no funciona o el paciente no cumple la prescripción?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "A. Puras" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "1997" "volumen" => "109" "paginaInicial" => "709" "paginaFinal" => "711" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cumplimiento terapéutico en el tratamiento de la hipertensión: 10 años de publicaciones en España" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Puigventós" 1 => "V. Llodrá" 2 => "M. Vilanova" 3 => "O. Delgado" 4 => "M. Lázaro" 5 => "J. Forteza-Rey" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "1997" "volumen" => "109" "paginaInicial" => "702" "paginaFinal" => "706" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.K. Jones" 1 => "L. Gorkin" 2 => "J.F. Lian" 3 => "J.A. Staffa" 4 => "A.P. Fletcher" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Br Med J" "fecha" => "1995" "volumen" => "311" "paginaInicial" => "293" "paginaFinal" => "295" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The costs of interrupting antihypertensive drug therapy in a Medicaid population" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.S. McCombs" 1 => "M.B. Nichol" 2 => "C.M. Newman" 3 => "D.A. Sclar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Med Care" "fecha" => "1994" "volumen" => "32" "paginaInicial" => "214" "paginaFinal" => "216" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8145599" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Changes in antihypertensive therapy. The role of adverse effects and compliance" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Düsing" 1 => "B. Weisser" 2 => "T. Mengden" 3 => "H. Vetter" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Blood Pressure" "fecha" => "1998" "volumen" => "7" "paginaInicial" => "313" "paginaFinal" => "315" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10321445" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Observancia del tratamiento antihipertensivo" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "V.F. Gil" 1 => "F. Piñeiro" 2 => "J. Merino" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Iberoamerican J Hypertens" "fecha" => "1997" "volumen" => "2" "paginaInicial" => "217" "paginaFinal" => "223" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The importance of drug combinations for effective control of hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J. Chalmers" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Exper Hypertens" "fecha" => "1999" "volumen" => "21" "paginaInicial" => "875" "paginaFinal" => "884" ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiologic research" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Klermbrum" 1 => "Kupper" 2 => "Morgenstern" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:1 [ "serieFecha" => "1982" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Grado de control y atención a los pacientes con hipertensión en el Área de Salud de Toledo" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "E. Sáez" 1 => "A. Millán" 2 => "F. López de Castro" 3 => "J. Carrasco" 4 => "A. Arribas" 5 => "M.J. Abarca" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aten Primaria" "fecha" => "1999" "volumen" => "24" "paginaInicial" => "559" "paginaFinal" => "562" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10659455" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evolución del control de la hipertensión arterial en España. Resultados del estudio Controlpres" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "A. Coca" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Hipertensión" "fecha" => "1998" "volumen" => "15" "paginaInicial" => "298" "paginaFinal" => "307" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "H. Olsen" 1 => "T. Klemetsrud" 2 => "H.P. Stokke" 3 => "S. Tretli" 4 => "A. Westheim" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Blood Pressure" "fecha" => "1999" "volumen" => "8" "paginaInicial" => "94" "paginaFinal" => "101" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10451036" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use and adverse reactions of antihypertensive drugs in Spain. Part I of the RAAE study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "P. Aranda" 1 => "J. Tamargo" 2 => "F.J. Aranda" 3 => "M. Luque" 4 => "A. López- García-Franco" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Blood Pressure" "fecha" => "1997" "volumen" => "6" "numero" => "Supl 1" "paginaInicial" => "11" "paginaFinal" => "16" ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Calidad de la prescripción de fármacos antihipertensivos en un área de salud" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Mateo" 1 => "A. Gil" 2 => "M.L. Sevillano" 3 => "L. Barutell" 4 => "A. Lorenzo" 5 => "Lucas Pérez de" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Aten Primaria" "fecha" => "2000" "volumen" => "25" "paginaInicial" => "302" "paginaFinal" => "307" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10853498" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The direct costs to the NHS of discontinuing and switching prescriptions for hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D. Hughes" 1 => "A. McGuire" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Human Hypertension" "fecha" => "1998" "volumen" => "12" "paginaInicial" => "533" "paginaFinal" => "537" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The costs of interrupting antihypertensive drug therapy in a medicaid population" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.S. McCombs" 1 => "M.B. Nichol" 2 => "C.M. Newman" 3 => "D.A. Sclar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Med Care" "fecha" => "1994" "volumen" => "32" "paginaInicial" => "214" "paginaFinal" => "226" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8145599" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Continuation of initial antihypertensive medication after 1 year of therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "B.S. Bloom" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Ther" "fecha" => "1998" "volumen" => "20" "paginaInicial" => "671" "paginaFinal" => "681" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9737827" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stepped care for hypertension: are the assumptions valid?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.J. Caro" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Hypertens Suppl" "fecha" => "1997" "volumen" => "15" "paginaInicial" => "S35" "paginaFinal" => "S39" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9532519" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydroclorothiazide, atenolol, felodipine ER and angiotensin- converting enzyme inhibitors for the treatment of systemic hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A.I. Goldberg" 1 => "M.C. Dunlay" 2 => "C.S. Sweet" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "1995" "volumen" => "75" "paginaInicial" => "759" "paginaFinal" => "793" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7717274" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "titulo" => "Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-VI)" ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med" "fecha" => "1997" "volumen" => "157" "paginaInicial" => "2413" "paginaFinal" => "2446" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9385294" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "titulo" => "Grupo de estudio sobre abordaje farmacológico de la Hipertensión Arterial en Atención Primaria (AFHAP). Selección del tratamiento farmacológico de la hipertensión arterial en Atención Primaria" ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2000" "volumen" => "114" "paginaInicial" => "374" "paginaFinal" => "377" ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Selección del tratamiento farmacológico inicial de la hipertensión arterial en Atención Primaria" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Albadalejo" 1 => "J.A. Martín" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2000" "volumen" => "115" "paginaInicial" => "78" "paginaFinal" => "79" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/00257753/0000011600000006/v1_201307291450/S0025775301717733/v1_201307291450/es/main.assets" "Apartado" => array:4 [ "identificador" => "24087" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Original breve" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00257753/0000011600000006/v1_201307291450/S0025775301717733/v1_201307291450/es/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775301717733?idApp=UINPBA00004N" ]
Información de la revista
Compartir
Descargar PDF
Más opciones de artículo
Análisis poblacional de la necesidad de cambios y tasas de continuidad de los diferentes fármacos antihipertensivos
A population-based study of need for changes and continuing rates of antihypertensive drugs